FDA
approval
· 2022-10-06
FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved Teva's supplemental application for CLARAVIS (isotretinoin), a supplemental approval for the product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLARAVIS (ISOTRETINOIN)